Skip to content
Recall Observatory FDA recall evidence

Drug product

Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01.

D-1496-2016

June 17, 2016

Class II

Product summary

Firm
Teva North America
Event
Event 74497
Status
Terminated
Classification
Class II
Quantity
14,661 vials
Official record key
drug-enforcement:D-1496-2016

Official wording

Reason: CGMP Deviations

Code information: All Lots Within Expiry Lot# 2710715, 2720715, 2730715, 3110715, 3120715

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations

Field note

Send feedback

We'll only use this to respond to your feedback.